Literature DB >> 20691826

High burden of cardiovascular disease risk factors in Mexico: An epidemic of ischemic heart disease that may be on its way?

Benjamín Acosta-Cázares1, Jorge Escobedo-de la Peña.   

Abstract

BACKGROUND: Whereas developed nations have witnessed a drop in the occurrence and mortality of ischemic heart disease, developing nations have recorded a constant rise. The burden of cardiovascular disease risk factors may explain this increase.
METHODS: We conducted a population-based cross-sectional survey to estimate the prevalence of cardiovascular risk factors in the population protected by the Mexican Social Security Institute. A total of 20,062 Mexicans, aged >or=20 years, 43.5% (8,727) male and 56.5% (11,335) female, randomly selected in a 4-stage stratified population-based sampling process were included.
RESULTS: The most prevalent cardiovascular risk factor in men was smoking (31.9%), whereas in women, it was obesity (26.6%) and central obesity (49.7%). A similar high age-adjusted prevalence was observed in women and men for hypertension (29.7% and 28.8%), diabetes (12.94% and 12.66%), and hypercholesterolemia (13.81% and 12.36%). There was a clear age effect on the prevalence of diabetes, hypertension, and hypercholesterolemia, with increasing prevalence with aging. Smoking also had an age effect, but its prevalence increases as age diminishes. More than half of the subjects in reproductive age (20-44 years old) have at least 1 cardiovascular risk factor, mainly smoking.
CONCLUSIONS: Cardiovascular risk factors are highly prevalent in the Mexican population, which seems to be between the second and third stages of the tobacco epidemic. The increased prevalence of risk factors clustering indicates the need for comprehensive integrated management of cardiovascular risk factors in Mexicans, with special emphasis on individuals at younger ages. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20691826     DOI: 10.1016/j.ahj.2010.05.016

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Prevalence of hypertension and associated risk factors in six Nicaraguan communities.

Authors:  Timothy S Laux; Philip J Bert; Marvin González; Mark Unruh; Aurora Aragon; Cecilia Torres Lacourt
Journal:  Ethn Dis       Date:  2012       Impact factor: 1.847

2.  Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study.

Authors:  Rui Wang; Laura Fratiglioni; Yajun Liang; Anna-Karin Welmer; Weili Xu; Francesca Mangialasche; Kristina Johnell; Chengxuan Qiu
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 3.  Opuntia spp.: Characterization and Benefits in Chronic Diseases.

Authors:  María Del Socorro Santos Díaz; Ana-Paulina Barba de la Rosa; Cécile Héliès-Toussaint; Françoise Guéraud; Anne Nègre-Salvayre
Journal:  Oxid Med Cell Longev       Date:  2017-04-09       Impact factor: 6.543

4.  Regional-level estimation of expected years of life lost attributable to overweight and obesity among Mexican adults.

Authors:  Efrén Murillo-Zamora; Raúl García-Ceballos; Iván Delgado-Enciso; Raquel Garza-Guajardo; Oralia Barboza-Quintana; Irám P Rodríguez-Sánchez; Oliver Mendoza-Cano
Journal:  Glob Health Action       Date:  2016-09-06       Impact factor: 2.640

5.  Assessing costs of a hypertension program in primary care: evidence from the HEARTS program in Mexico.

Authors:  Carlos Chivardi; Brian Hutchinson; Virginia Molina; Elena Moreno; Ileana Fajardo; Gloria P Giraldo-Arcila; Hugo Miguel Malo; Pedro Ordunez; Roxana Rodríguez-Franco; Andrew E Moran; Deliana Kostova
Journal:  Rev Panam Salud Publica       Date:  2022-09-15

6.  Improving heart healthy lifestyles among participants in a Salud para su Corazón promotores model: the Mexican pilot study, 2009-2012.

Authors:  Héctor Balcázar; Ana Cecilia Fernández-Gaxiola; Ana Bertha Pérez-Lizaur; Rosa Adriana Peyron; Carma Ayala
Journal:  Prev Chronic Dis       Date:  2015-03-12       Impact factor: 2.830

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.